marijuana stocks news

Form 8-K for LEXARIA BIOSCIENCE CORP.


7-Jun-2016

Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01 Regulation FD DisclosureA copy of the news release announcing our intention to complete an equity financing of CDN$100,000 is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

Item 9.01 Financial Statements and Exhibits99.1 Press Release dated May 31, 2016


– 2 –

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cara Therapeutics, Inc. (CARA) to Announce Fourth Quarter and Full Year 2019 Financial Results

Cara Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results…

Aphria (APHA) Sign Deal to Develop Cannabis Transdermal Patches

Aphria, Manna Sign Deal to Develop Cannabis Transdermal Patches Aphria (TSX: APHA) (NYSE: APHA) said…

$CBIS Acquires Pet Care Manufacturer and Distributor Equi-Pharm

Cannabis Science Acquires Pet Care Manufacturer and Distributor Equi-Pharm & Enters the…

$ENRT Announces Joint Venture with Lexaria for Medical MJ Advisory Board

Enertopia and Lexaria Launch Medical Advisory Board Vancouver, BC / ACCESSWIRE /…